FL HB 1381
deadExperimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Florida · 2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did FL HB 1381 pass?
No. FL HB 1381 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-03-13): Died in Health Professions & Programs Subcommittee
What is FL HB 1381 about?
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases; Authorizes licensed physicians to prescribe & eligible facilities to administer experimental treatments; requires approval of specified platform or master protocol by institutional review board; requires DOH to establish & maintain patient registry; requires DOH to annually publish specified report; encourages health insurers & health maintenance organizations to provide specified insurance coverage for experimental treatments; authorizes licensed physicians & eligible facilities to receive reimbursement for experimental treatments; requires manufacturers of experimental treatments to provide for specified temporary price concession; requires DOH to adopt by rule certain procedures for licensing of experimental treatment centers.
Who sponsors FL HB 1381?
Franklin is the primary sponsor of FL HB 1381.
Description
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases; Authorizes licensed physicians to prescribe & eligible facilities to administer experimental treatments; requires approval of specified platform or master protocol by institutional review board; requires DOH to establish & maintain patient registry; requires DOH to annually publish specified report; encourages health insurers & health maintenance organizations to provide specified insurance coverage for experimental treatments; authorizes licensed physicians & eligible facilities to receive reimbursement for experimental treatments; requires manufacturers of experimental treatments to provide for specified temporary price concession; requires DOH to adopt by rule certain procedures for licensing of experimental treatment centers.
- Introduced
- —
- Latest action
- 2026-03-13 — Died in Health Professions & Programs Subcommittee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Franklinprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-03-13
Died in Health Professions & Programs Subcommittee
failure
2026-01-15
Now in Health Professions & Programs Subcommittee
2026-01-15
Referred to Health & Human Services Committee
referral-committee
2026-01-15
Referred to Health Care Budget Subcommittee
referral-committee
2026-01-15
Referred to Health Professions & Programs Subcommittee
referral-committee
2026-01-13
1st Reading (Original Filed Version)
filing,reading-1
2026-01-09
Filed
filing
Versions
- H 1381 FiledCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:19:20.677932Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=FL&identifier=HB 1381. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.